Arvin Yang

2022

In 2022, Arvin Yang earned a total compensation of $1.5M as Senior Vice President, Chief Medical Officer at Mersana Therapeutics, a 77% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$245,450
Option Awards$582,726
Salary$527,850
Stock Awards$177,931
Other$7,000
Total$1,540,957

Yang received $582.7K in option awards, accounting for 38% of the total pay in 2022.

Yang also received $245.5K in non-equity incentive plan, $527.9K in salary, $177.9K in stock awards and $7K in other compensation.

Rankings

In 2022, Arvin Yang's compensation ranked 2,169th out of 5,753 executives tracked by ExecPay. In other words, Yang earned more than 62.3% of executives.

ClassificationRankingPercentile
All
2,169
out of 5,753
62nd
Division
Manufacturing
1,170
out of 3,133
63rd
Major group
Chemicals And Allied Products
504
out of 1,419
65th
Industry group
Drugs
464
out of 1,320
65th
Industry
Pharmaceutical Preparations
338
out of 966
65th

Pay ratio

Arvin Yang's Pay$1,540,957
Median Employee's Pay$243,051
Pay Ratio

6

to 1

In 2022, the annual total compensation of Arvin Yang was $1,540,957.

The annual total compensation of the median employee at Mersana Therapeutics was $243,051.

The ratio of Arvin Yang's pay to the pay of median employee was therefore 6 to one.

Source: SEC filing on April 28, 2023.

Yang's colleagues

We found four more compensation records of executives who worked with Arvin Yang at Mersana Therapeutics in 2022.

2022

Anna Protopapas

Mersana Therapeutics

Chief Executive Officer

2022

Brian DeSchuytner

Mersana Therapeutics

Chief Financial Officer

2022

Timothy Lowinger

Mersana Therapeutics

Chief Science and Technology Officer

2022

Alejandra Carvajal

Mersana Therapeutics

Chief Legal Officer

News

You may also like